Wang Wenyi, Liu Xiaoxu, Dang Jun, Li Guang
Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Front Oncol. 2023 Mar 24;13:1132423. doi: 10.3389/fonc.2023.1132423. eCollection 2023.
To compare the lesion characteristics and radiotherapy efficacy of patients with single and multiple esophageal squamous cell carcinoma (ESCC), to evaluate the effect of multiple lesions on ESCC, and establish a nomogram survival prediction model for patients with synchronous multiple primary esophageal squamous cell carcinoma (SMPESCC) who received definitive radiotherapy.
The study enrolled 1,034 patients with ESCC who underwent definitive radiotherapy between 2010 and 2020. The efficacy of radiotherapy was compared between 101 patients with SMPESCC and 933 patients with single ESCC. Propensity score matching was used to control for potential confounders. For patients with SMPESCC, a nomogram prediction model was established based on the Cox regression model.
The median OS was 30.00 (95% CI = 25.08-34.92) months for the single lesion group and 19.00 (95% CI = 15.51-22.48) months for the multiple cancer group respectively. Multivariate COX regression analysis showed that multiple cancer was an independent prognostic factor for ESCC patients (HR=1.89, 95%CI=1.49-2.38, P<0.001). Cox multivariate analysis of SMPESCC patients showed that T stage (P =0.002), chemotherapy (P =0.006), and lesion spacing (P =0.004) were independent prognostic factors associated with OS. The nomogram was established by combining T stage, chemotherapy, and lesion spacing, and Harrell's C index was 0.711 after internal cross-validation. The calibration curve and decision curve analysis confirmed that the nomogram survival prediction model had a good predictive value for individual survival.
The survival rate of single esophageal cancer is significantly better than that of multiple lesions. Patients with SMPESCC exhibit worse survival than patients with single ESCC. Multiple lesions have a significant impact on the survival of patients with ESCC. The nomogram model established for SMPESCC patients can well predict the individual survival of patients.
比较单发性和多发性食管鳞状细胞癌(ESCC)患者的病变特征及放射治疗疗效,评估多发病变对ESCC的影响,并为接受根治性放疗的同步多发原发性食管鳞状细胞癌(SMPESCC)患者建立列线图生存预测模型。
本研究纳入了2010年至2020年间接受根治性放疗的1034例ESCC患者。比较了101例SMPESCC患者和933例单发性ESCC患者的放疗疗效。采用倾向评分匹配法控制潜在混杂因素。对于SMPESCC患者,基于Cox回归模型建立列线图预测模型。
单发病变组的中位总生存期(OS)为30.00(95%CI = 25.08 - 34.92)个月,多发癌组为19.00(95%CI = 15.51 - 22.48)个月。多因素COX回归分析显示,多发癌是ESCC患者的独立预后因素(HR = 1.89,95%CI = 1.49 - 2.38,P < 0.001)。对SMPESCC患者的Cox多因素分析显示,T分期(P = 0.002)、化疗(P = 0.006)和病变间距(P = 0.004)是与OS相关的独立预后因素。通过结合T分期、化疗和病变间距建立列线图,内部交叉验证后Harrell's C指数为0.711。校准曲线和决策曲线分析证实列线图生存预测模型对个体生存具有良好的预测价值。
单发性食管癌的生存率明显优于多发病变者。SMPESCC患者的生存情况比单发性ESCC患者更差。多发病变对ESCC患者的生存有显著影响。为SMPESCC患者建立的列线图模型能够很好地预测患者个体生存情况。